You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-CDKN1A (CDKN1A) Antibodies

Full name:
anti-Cyclin-Dependent Kinase Inhibitor 1A Antibodies (CDKN1A)
On are 4 Cyclin-Dependent Kinase Inhibitor 1A (CDKN1A) Antibodies from 2 different suppliers available. Additionally we are shipping CDKN1A Kits (5) and CDKN1A Proteins (2) and many more products for this protein. A total of 11 CDKN1A products are currently listed.
CAP20, CDKI, Cdkn1, CIP1, MDA-6, mda6, P21, p21Cip1, p21WAF, SDI1, Waf1
list all antibodies Gene Name GeneID UniProt
CDKN1A 1026 P38936
Anti-Mouse CDKN1A CDKN1A 12575 P39689

Show all species

Show all synonyms

Most Popular Reactivities for anti-CDKN1A (CDKN1A) Antibodies

Select your species and application

anti-Human CDKN1A Antibodies:

anti-Rat (Rattus) CDKN1A Antibodies:

All available anti-CDKN1A Antibodies

Go to our pre-filtered search.

More Antibodies against CDKN1A Interaction Partners

Human Cyclin-Dependent Kinase Inhibitor 1A (CDKN1A) interaction partners

  1. these findings indicated that HMGB1 (show HMGB1 Antibodies) promoted hepatocellular carcinoma progression partly by enhancing the ERK1/2 (show MAPK1/3 Antibodies) and NF-kappaB (show NFKB1 Antibodies) pathways, upregulating MMP-2 (show MMP2 Antibodies), and downregulating p21 via an ERK (show EPHB2 Antibodies)/c-Myc (show MYC Antibodies) pathway

  2. High CIP1 expression is associated with metastasis occurrence in Prostate Cancer.

  3. Results indicated that p21 was responsible for the downregulation of G2/M transition regulatory proteins and the bypass of mitosis induced by irradiation.

  4. JMJD5 (show JMJD5 Antibodies) is a tumor suppressor gene in HCC (show FAM126A Antibodies) pathogenesis, and the epigenetic silencing of JMJD5 (show JMJD5 Antibodies) promotes HCC (show FAM126A Antibodies) cell proliferation by directly down-regulating CDKN1A transcription.

  5. Nested multiplex polymerase chain reactions to detect the presence of the HPV types, as well as immunohistochemical reactions were performed for the detection of cell cycle-related proteins p16 (show CDKN2A Antibodies), p27 (show PAK2 Antibodies), p53 (show TP53 Antibodies) and Ki-67 (show MKI67 Antibodies). The expression of all analyzed cell cycle-related proteins was increased in HPV-infected papillomas

  6. High expression of CIP1 is associated with recurrence in oral squamous cell carcinoma.

  7. Urolithin A incubation caused the up-regulation of CDKN1A and down-regulation of FN-1 (show FN1 Antibodies) in prostate cancer cells.

  8. Results show that while HOXB13 (show HOXB13 Antibodies) suppressed p21 expression via regulation of JNK (show MAPK8 Antibodies) signals, alteration of p21 expression also affected c-Jun (show JUN Antibodies) and AP-1 (show FOSB Antibodies) activity in prostate cancer cells.

  9. HIF-alpha promotes chronic CML (show BCR Antibodies) cell proliferation by up-regulating p21 expression

  10. Alterations in p53 (show TP53 Antibodies) and p21 expression suggest that these proteins are involved in lower lip carcinogenesis. Moreover, p53 (show TP53 Antibodies) and hMSH2 (show MSH2 Antibodies) seem to be interrelated in early events of this process.

Mouse (Murine) Cyclin-Dependent Kinase Inhibitor 1A (CDKN1A) interaction partners

  1. lincRNA-p21 (show D4S234E Antibodies) overexpression dramatically inhibited acetylation of H3 and H4 at the Thy-1 (show THY1 Antibodies) promoter and Thy-1 (show THY1 Antibodies) expression levels in HLF1 (show HLF Antibodies) cells. Finally, lincRNA-p21 (show D4S234E Antibodies) interference rescued LPS (show TLR4 Antibodies)-induced increase of lung and BAL collagen contents. LincRNA-p21 (show D4S234E Antibodies) could lead to pulmonary fibrosis in ARDS by inhibition of the expression of Thy-1 (show THY1 Antibodies).

  2. p21 (show D4S234E Antibodies) upregulation in hair follicle stem cells is associated with telogen retention in aged mice

  3. MiR-17-92 functions as a hepatocyte proliferation stimulator and acts in an estrogen-dependent manner. The loss of this miRNA results in increases in p21 (show D4S234E Antibodies) and Pten (show PTEN Antibodies) expression and therefore impairs liver regeneration in female mice.

  4. we observed that miR (show MLXIP Antibodies)-378 modulates the oscillation amplitudes of Cdkn1a in the control of cell cycle and Por (show POR Antibodies) in the regulation of oxidation reduction by forming partnership with different circadian transcription factors

  5. The findings define PRMT7 (show PRMT7 Antibodies) as a regulator of the DNMT3b (show DNMT3B Antibodies)/p21 (show D4S234E Antibodies) axis required to maintain muscle stem cell regenerative capacity.

  6. Dynamics of CDKN1A in single cells has been defined defined by an endogenous fluorescent tagging.

  7. Ablation of p21Cip1 in the Cdk4 (show CDK4 Antibodies) R24C background accelerates mesenchymal tumor development in mice.

  8. The lack of functional Waf1 is indispensable for maintaining self-renewal and pluripotency of embryonic stem cells.

  9. p27(Kip1 (show CDKN1B Antibodies)) and p21(Cip1) are insufficient for the proliferative inhibition of smooth muscle cells cultured in type 1 collagen.

  10. Foxo3 (show FOXO3 Antibodies) circular RNA retards cell cycle progression via forming ternary complexes with p21 (show D4S234E Antibodies) and CDK2 (show CDK2 Antibodies).

CDKN1A Antigen Profile

Antigen Summary

This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen (PCNA), a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Multiple alternatively spliced variants have been found for this gene.

Alternative names and synonyms associated with CDKN1A

  • cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A) antibody
  • cyclin-dependent kinase inhibitor 1A (P21) (Cdkn1a) antibody
  • CAP20 antibody
  • CDKI antibody
  • Cdkn1 antibody
  • CIP1 antibody
  • MDA-6 antibody
  • mda6 antibody
  • P21 antibody
  • p21Cip1 antibody
  • p21WAF antibody
  • SDI1 antibody
  • Waf1 antibody

Protein level used designations for CDKN1A

CDK-interacting protein 1 , CDK-interaction protein 1 , DNA synthesis inhibitor , cyclin-dependent kinase inhibitor 1 , melanoma differentiation associated protein 6 , wild-type p53-activated fragment 1 , melanoma differentiation-associated protein , p21

1026 Homo sapiens
12575 Mus musculus
Selected quality suppliers for anti-CDKN1A (CDKN1A) Antibodies
Did you look for something else?